Genmab A (GMAB) Goodwill (2024 - 2026)

Genmab A (GMAB) has reported Goodwill for 3 consecutive years, with $355.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Goodwill changed 0.0% year-over-year to $355.0 million; the trailing twelve-month figure through Jun 2026 stood at $355.0 million (changed 0.0% YoY), and the FY2025 full-year result was $355.0 million, changed 0.0% from the prior year.
• Goodwill held at $355.0 million in Q2 2026 per GMAB's latest filing, from $355.0 million in the prior quarter.
• Across five years, Goodwill topped out at $355.0 million in Q1 2025 and bottomed at $4.8 million in Q4 2024.
• Historically, Goodwill has averaged $289.1 million across 3 years, with a median of $355.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Goodwill jumped 7237.44% in 2025, then changed 0.0% in 2026.
• Over 3 years, Goodwill stood at $4.8 million in 2024, then surged by 7237.44% to $355.0 million in 2025, then changed by 0.0% to $355.0 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $355.0 million, $355.0 million, and $355.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.